NCT06342232

Brief Summary

This longitudinal randomized controlled trial explored how long-term practice of neurofeedback mindfulness would be helpful for migraine management when compare dot a similar controlled intervention. All the participants went through assigned 10 minutes practices on a daily basis for 8 weeks. Behavioural reports and migraine characteristics were compared before and after the intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
101

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 9, 2021

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 24, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2023

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

March 26, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 2, 2024

Completed
Last Updated

April 2, 2024

Status Verified

March 1, 2024

Enrollment Period

1.3 years

First QC Date

March 26, 2024

Last Update Submit

March 26, 2024

Conditions

Keywords

migraineneurofeedback mindfulnessRCT

Outcome Measures

Primary Outcomes (3)

  • Migraine Disability

    Based on MIDAS scale

    8 Weeks

  • Migraine Severity

    Based on Hit-6 Scale

    8 Weeks

  • Headache Management Self-efficacy

    Based on HMSE scale

    8 Weeks

Secondary Outcomes (2)

  • Anxiety

    8 Weeks

  • Depression

    8 Weeks

Study Arms (2)

Neurofeedback Mindfulness

EXPERIMENTAL

The participants received 8 weeks of intervention (10 min/day) including a neurofeedback mindfulness exercise via a portable EEG headband.

Behavioral: Neurofeedback mindfulness

Simple Attention Task

ACTIVE COMPARATOR

In the control group, the participants used the portable EEG headband for the same duration of intervention (8 weeks of practice, 10 min/day), but only listened to an audiobook without realtime access to their EEG recordings.

Behavioral: Simple attention controlled task

Interventions

The participants used a portable EEG headband to complete 10 minutes of neurofeedback mindfulness practice for 8 weeks. While being seated comfortably, they could modify their brains rates based on the audio neurofeedback they received.

Neurofeedback Mindfulness

The controlled group of this project also received an intervention which included an audiobook. While wearing the headband, the controlled participants muted their neurofeedback sounds and only focused on an audiobook while remaining relaxed. A summary of their brain states was given to them when completing their practice every day.

Simple Attention Task

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age (over 18 years of age)
  • a migraine diagnosis or having met the criteria for any type of migraine diagnosis based on ICHD-3 4. residing in Saskatoon or being able to receive the device from Saskatoon and the communities nearby
  • having a smartphone and internet connection for accessing the MUSE app

You may not qualify if:

  • Frequent background experience of meditation
  • Comorbidity of Raynaud's syndrome or diabetes
  • Current use of a preventative migraine treatment over 6 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Saskatchewan

Saskatoon, Saskatchewan, S7N5A2, Canada

Location

MeSH Terms

Conditions

Migraine Disorders

Condition Hierarchy (Ancestors)

Headache Disorders, PrimaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. Marla Mickleborough

Study Record Dates

First Submitted

March 26, 2024

First Posted

April 2, 2024

Study Start

September 9, 2021

Primary Completion

December 24, 2022

Study Completion

March 1, 2023

Last Updated

April 2, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations